JENNY SANCHEZ: Open Payments
NPI 1841744745 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 9 payments from 7 companies in 2025. Trend: 2023 $479 · 2024 $415 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $48 |
| Calliditas Therapeutics US Inc. | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $13 |
Products named: DUPIXENT, TARPEYO, TAVNEOS, KRYSTEXXA, Fabhalta, Ozempic, Kerendia.
Industry payments across NV — which companies pay providers there.
